Rare Cancers Bill 2024-2025
The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.

MPs will debate the Implementation of the UK Rare Diseases Framework on Wednesday 24 March at 4.50pm. The debate will be led by Liz Twist MP.
Implementation of the UK Rare Diseases Framework (163 KB , PDF)
In January 2021, the Department of Health and Social Care (DHSC) published the UK Rare Diseases Framework which set out a ‘community-led vision to build upon existing UK strengths and improve areas of weakness to deliver better health outcomes and improve the lives of those living with rare diseases’.[1] The Framework follows on from a 2013 strategy which was due to end in 2020.
The Framework defines a rare disease as a condition which affects less than 1 in 2,000 people and covers over 7,000 rare diseases.[2] Whilst 80% of rare diseases have an identified genetic origin, other causes include disordered immunity, infections, allergies, deterioration of body tissues and organs or disruption to development while in the womb.[3]
Rare diseases are individually rare but can affect up to 1 in 17 people at some point in their lifetime, amounting to over 3.5 million people in the UK.[4]
Rare diseases can be life-limiting and life-threatening and disproportionately affect children. 75% of rare diseases affect children and more than 30% of children with a rare disease die before their fifth birthday.[5]
Following the Framework’s publication, the four UK nations are now set to develop action plans which will set out how the Framework’s priorities will be addressed in each respective nation, taking into account the Framework’s priorities and themes. Where possible, each nation will publish the action plans in 2021.
[1] DHSC, UK Rare Diseases Framework, 9 Jan 2021
[2] DHSC, UK Rare Diseases Framework, 9 Jan 2021
[3] DHSC, UK Rare Diseases Framework, 9 Jan 2021
[4] DHSC, UK Rare Diseases Framework, 9 Jan 2021
[5] DHSC, UK Rare Diseases Framework, 9 Jan 2021
Implementation of the UK Rare Diseases Framework (163 KB , PDF)
The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.
This briefing focuses on two disease-modifying dementia drugs that are currently being appraised by the National Institute for Health and Care Excellence (NICE): lecanemab and donanemab
On 8 July 2025, there will be a Commons debate on alcohol and cancer. The debate will be led by Cat Smith MP. The Library will publish a briefing ahead of the debate.